Staurosporine potentiates platelet activating factor stimulated phospholipase C activity in rabbit platelets but does not block desensitization by platelet activating factor

Life Sci. 1989;45(4):333-9. doi: 10.1016/0024-3205(89)90143-4.

Abstract

The possible involvement of protein kinase C activation in regulating PAF-stimulated PLC activity was studied in rabbit platelets. PAF (100 nM for 5 seconds) stimulated incorporation of 32P into proteins and caused [3H]InsP3 levels to increase about 260% of control. These responses were compared after platelets were pretreated with either PAF, phorbol 12-myristate 13-acetate (PMA) or staurosporine and also after pretreatments with staurosporine followed by PAF or PMA. Pretreating platelets with staurosporine potentiated PAF-stimulated [3H]InsP3 levels by 54% and blocked protein phosphorylation. Pretreatments with PAF and PMA caused PAF-stimulated [3H]InsP3 levels to decrease to 115 and 136%, respectively. Staurosporine pretreatment blocked the decrease caused by the PMA pretreatment but not that by PAF. This study demonstrates that PAF-stimulated PLC activity is negatively affected by protein kinase C (PKC) activation and that inhibition of PKC activity did not prevent desensitization of PLC by PAF.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkaloids / pharmacology*
  • Animals
  • Blood Platelets / drug effects
  • Blood Platelets / enzymology*
  • Drug Synergism
  • In Vitro Techniques
  • Inositol / blood
  • Inositol Phosphates / blood
  • Kinetics
  • Phosphorylation
  • Platelet Activating Factor / pharmacology*
  • Protein Kinase C / antagonists & inhibitors*
  • Rabbits
  • Staurosporine
  • Tetradecanoylphorbol Acetate / pharmacology
  • Type C Phospholipases / blood*

Substances

  • Alkaloids
  • Inositol Phosphates
  • Platelet Activating Factor
  • Inositol
  • Protein Kinase C
  • Type C Phospholipases
  • Staurosporine
  • Tetradecanoylphorbol Acetate